| Literature DB >> 30416461 |
Carola Schildbach1, Sebastian Schildbach1.
Abstract
Background: Inmates are several times more likely to suffer from mental disorders than the general population.In order to take appropriate curative or preventive measures, a precise psychiatric diagnosis at detention start would therefore be imperative, but is frequently not carried out for reasons of time. The computer-aided expert system DIA-X enables a rapid and reliable diagnosis of psychiatric disorders. DIA-X is available as a short screening questionnaire with a processing time of a few minutes and as a standardized interview, which takes ~1 h to complete. Objective: The aim of this study was to assess the efficiency and accuracy of the DIA-X short screening questionnaire.Entities:
Keywords: DIA-X; compensation imprisonment; mental disorder screening; predictive values; sensitivity and specificity
Year: 2018 PMID: 30416461 PMCID: PMC6212464 DOI: 10.3389/fpsyt.2018.00538
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Demographic characteristics of the study population in 2017 (n = 100).
| Mean age in years | 37.2 |
| Proportion of singles | 92% |
| Proportion of inmates with no fixed address or in residential facilities | 38% |
| Inmates without a school-leaving qualification | 30% |
| Inmates without a vocational training | 41% |
| Unemployment rate | 85% |
| Convicted for fare evasion | 49% |
| Convicted for other petty crimes | 15% |
| Convicted for property crimes | 21% |
| Convicted for personal injuries | 7% |
| Convicted for road traffic offences | 5% |
| Convicted for insulting others | 3% |
| Nicotine dependency | 58% |
| Cannabis abuse | 33% |
| Opioid abuse | 30% |
| Cocaine abuse | 21% |
| Other stimulant abuse | 20% |
| Hallucinogen abuse | 12% |
| Sedative, hypnotic or anxiolytic-related abuse | 6% |
Overview of the average prevalence of mental disorders in four study populations of compensation imprisoners from the years 1999, 2004, 2010, and 2017 (n = 400). Multiple answers with respect to mental disorders were possible.
| F10 | Mental and behavioral disorders due to use of alcohol | 72.75 |
| F11, F12, F14–16 | Mental and behavioral disorders due to use of opioids, cannabinoids, cocaine, or hallucinogens | 45.5 |
| F13 | Mental and behavioral disorders due to use of sedatives or hypnotics | 5.25 |
| F17.2 | Nicotine dependency | 65.75 |
| F20–F29 | Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders | 3.75 |
| F30 | Hypomania | 3 |
| F32–F33 | Depressive disorders | 26.25 |
| F34.1 | Dysthymia | 11.5 |
| F40 | Phobic anxiety disorders | 35 |
| F41 | Other anxiety disorders | 5.75 |
| F43 | Reaction to severe stress, and adjustment disorders | 7 |
| F45 | Somatoform disorders | 16 |
| F50 | Eating disorders | 2.25 |
Sensitivity and specificity of the DIA-X short form as obtained by comparing its diagnostic results to those received from the DIA-X long form (n = 100).
| F10 | Mental and behavioral disorders due to use of alcohol | 100 | 50 |
| F11, F12, F14–16 | Mental and behavioral disorders due to use of opioids, cannabinoids, cocaine, or hallucinogens | 100 | 26 |
| F13 | Mental and behavioral disorders due to use of sedatives or hypnotics | 100 | 81 |
| F17.2 | Nicotine dependency | 100 | 23 |
| F20–F29 | Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders | 100 | 99 |
| F30 | Hypomania | 100 | 76 |
| F32–F33 | Depressive disorders | 100 | 56 |
| F34.1 | Dysthymia | 100 | 69 |
| F40 | Phobic anxiety disorders | 100 | 91 |
| F41 | Other anxiety disorders | 100 | 87 |
| F43 | Reaction to severe stress, and adjustment disorders | 100 | 82 |
| F45 | Somatoform disorders | 100 | 96 |
| F50 | Eating disorders | 100 | 95 |
Negative predictive value (NPV) and positive predictive value (PPV) of the DIA-X short form, based on the average prevalence of the respective mental disorder in compensation prisoners (n = 100).
| F10 | Mental and behavioral disorders due to use of alcohol | 33.2 | 67.4 |
| F11, F12, F14–16 | Mental and behavioral disorders due to use of opioids, cannabinoids, cocaine, or hallucinogens | 20.4 | 80.4 |
| F13 | Mental and behavioral disorders due to use of sedatives or hypnotics | 39.8 | 60.7 |
| F17.2 | Nicotine dependency | 18.6 | 82.2 |
| F20–F29 | Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders | 42.3 | 58.2 |
| F30 | Hypomania | 33.9 | 66.7 |
| F32–F33 | Depressive disorders | 35.2 | 65.4 |
| F34.1 | Dysthymia | 38.9 | 61.7 |
| F40 | Phobic anxiety disorders | 47.2 | 53.4 |
| F41 | Other anxiety disorders | 42.1 | 58.5 |
| F43 | Reaction to severe stress, and adjustment disorders | 41.5 | 59.0 |
| F45 | Somatoform disorders | 47.6 | 52.9 |
| F50 | Eating disorders | 34.8 | 65.7 |